Guggenheim Capital’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-13,488
| Closed | -$28K | – | 2665 |
|
|
2018
Q1 | $28K | Buy |
13,488
+82
| +0.6% | +$170 | ﹤0.01% | 2729 |
|
|
2017
Q4 | $27K | Sell |
13,406
-1,674
| -11% | -$3.37K | ﹤0.01% | 2661 |
|
|
2017
Q3 | $20K | Buy |
15,080
+2
| +0% | +$3 | ﹤0.01% | 2747 |
|
|
2017
Q2 | $24K | Sell |
15,078
-1,636
| -10% | -$2.6K | ﹤0.01% | 2773 |
|
|
2017
Q1 | $53K | Buy |
16,714
+12
| +0.1% | +$38 | ﹤0.01% | 2730 |
|
|
2016
Q4 | $22K | Buy |
16,702
+47
| +0.3% | +$62 | ﹤0.01% | 2844 |
|
|
2016
Q3 | $26K | Buy |
+16,655
| New | +$26K | ﹤0.01% | 2803 |
|
|
2015
Q1 | – | Sell |
-183,942
| Closed | -$3.11M | – | 3087 |
|
|
2014
Q4 | $3.11M | Buy |
+183,942
| New | +$3.11M | 0.01% | 1408 |
|
|
2014
Q1 | – | Sell |
-184,336
| Closed | -$2.55M | – | 3286 |
|
|
2013
Q4 | $2.55M | Buy |
184,336
+24,520
| +15% | +$339K | 0.01% | 1534 |
|
|
2013
Q3 | $2.79M | Buy |
159,816
+40,007
| +33% | +$698K | 0.01% | 1368 |
|
|
2013
Q2 | $1.95M | Buy |
+119,809
| New | +$1.95M | 0.01% | 1520 |
|